Advanced search
1 file | 442.11 KB Add to list

Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU

Author
Organization
Abstract
Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.
Keywords
EU, comparative effectiveness, medical need, level of innovation, orphan medicines, pharmaceutical innovation, personalized medicine

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 442.11 KB

Citation

Please use this url to cite or link to this publication:

MLA
Annemans, Lieven, Irina Cleemput, Frank Hulstaert, et al. “Comparative Effectiveness Research and Measuring the Level of Pharmaceutical Innovation in the EU.” JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH 1.1 (2012): 19–29. Print.
APA
Annemans, Lieven, Cleemput, I., Hulstaert, F., & Simoens, S. (2012). Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 1(1), 19–29.
Chicago author-date
Annemans, Lieven, Irina Cleemput, Frank Hulstaert, and Steven Simoens. 2012. “Comparative Effectiveness Research and Measuring the Level of Pharmaceutical Innovation in the EU.” Journal of Comparative Effectiveness Research 1 (1): 19–29.
Chicago author-date (all authors)
Annemans, Lieven, Irina Cleemput, Frank Hulstaert, and Steven Simoens. 2012. “Comparative Effectiveness Research and Measuring the Level of Pharmaceutical Innovation in the EU.” Journal of Comparative Effectiveness Research 1 (1): 19–29.
Vancouver
1.
Annemans L, Cleemput I, Hulstaert F, Simoens S. Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2012;1(1):19–29.
IEEE
[1]
L. Annemans, I. Cleemput, F. Hulstaert, and S. Simoens, “Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU,” JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, vol. 1, no. 1, pp. 19–29, 2012.
@article{5674285,
  abstract     = {Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.},
  author       = {Annemans, Lieven and Cleemput, Irina and Hulstaert, Frank and Simoens, Steven},
  issn         = {2042-6305},
  journal      = {JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH},
  keywords     = {EU,comparative effectiveness,medical need,level of innovation,orphan medicines,pharmaceutical innovation,personalized medicine},
  language     = {eng},
  number       = {1},
  pages        = {19--29},
  title        = {Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU},
  url          = {http://dx.doi.org/10.2217/CER.11.1},
  volume       = {1},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: